Evaluation of Spironolactone in Combination with Furosemide in Cirrhotic Patients with Permagna (Large) Ascites
Tuty Mulyani(1*), Fita Rahmawati(2), Neneng Ratnasari(3)
(1) Faculty of Pharmacy, Banjarmasin Muhammadiyah Health College
(2) Faculty of Pharmacy, Univesitas Gadjah Mada
(3) RSUP Dr. Sardjito Yogyakarta Faculty of Medicine, Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Sease JM, Timm EG, Stragand JJ. Portal Hypertension and Cirrhosis. In: DiPiro J, Talbert RL, Yee G, Wells B, Posey L., eds. Pharmacotherapy A Pathophysiologic Approach. 9th ed. McGraw Hill Professional; 2014.
Runyon BA. Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012. Am Assoc Study Liver Dis Pract Guidel. 2013:2087-2107.
Lee JM, Han K-H, Ahn SH. Ascites and spontaneous bacterial peritonitis: an Asian perspective. J Gastroenterol Hepatol. 2009;24(9):1494-1503. doi:10.1111/j.1440-1746.2009.06020.x.
European Association for the Study of the Liver. EASL: clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-417.
Kashani A, Landaverde C, Medici V, Rossaro L. Fluid retention in cirrhosis: Pathophysiology and management. Qjm. 2008;101(2):71-85. doi:10.1093/qjmed/hcm121.
Santos J, Planas R, Pardo A, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J Hepatol. 2003;39(2):187-192. doi:10.1016/S0168-8278(03)00188-0.
Angeli P, Fasolato S, Mazza E, et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut. 2010;59(1):98-104. doi:10.1136/gut.2008.176495.
Kuiper JJ, van Buuren HR, de Man RA. Ascites in cirrhosis: A review of management and complications. Neth J Med. 2007;65(8):283-288.
Thomas MN, Sauter GH, Gerbes AL, et al. Automated low flow pump system for the treatment of refractory ascites: a single-center experience. Langenbeck’s Arch Surg. 2015;400(8):979-983. doi:10.1007/s00423-015-1356-1.
Pere Gines, Paolo Angeli, Kurtz lenz, Soren Moller, Kevin Moore, Richard Moreau, Carlo Merkel GG-T. Clinical Practice Guidelines EASL clinical practice guidelines on the management of ascites , spontaneous bacterial peritonitis , and hepatorenal syndrome in cirrhosis Clinical Practice Guidelines. J Hepatol. 2010;53(May):397-417. doi:10.1016/j.jhep.2010.05.004.
Yakar T, Demir M, Dogan O, Ozer B, Serin E. High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis. 2016;39(6):52-60.
Rosner MH, Gupta R, Ellison D, Okusa MD. Management of cirrhotic ascites: Physiological basis of diuretic action. Eur J Intern Med. 2006;17(1):8-19. doi:10.1016/j.ejim.2005.08.003.
Shaikh S, Mal G, Khalid S, Baloch GH, Akbar Y. Frequency of hyponatraemia and its influence on liver cirrhosis-related complications. J Pak Med Assoc. 2010;60(2):116-120.
Farida Y. Analisis penggunaan obat pada komplikasi sirosis hati. J Manaj dan Pelayanan Farm. 2013;4:77-84.
Fortune B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep. 2017;5(2):104-112. doi:10.1093/gastro/gox010.
Raza MA, Qureshi UF, Humayoun MA, Waseem T, Akram J. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites. Eur J Gastroenterol Hepatol. 2011;23(2):184-188. doi:10.1097/MEG.0b013e328342af25.
Yan L, Xie F, Lu J, et al. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65. doi:10.1186/s12876-015-0297-z.
Moore KP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55(suppl_6):vi1-vi12. doi:10.1136/gut.2006.099580.
El-Bokl MA, Senousy BE, El-Karmouty KZ, et al. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites. World J Gastroenterol. 2009;15(29):3631-3635. doi:10.3748/wjg.15.3631.
Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome. Eur J Gastroenterol Hepatol. 2016;28(3):e10-e18. doi:10.1097/MEG.0000000000000548.
Senousy BE, Draganov P V. Evaluation and management of patients with refractory ascites. World J Gastroenterol. 2009;15(1):67-80. doi:10.3748/wjg.15.67.
Rena NMR a, Wibawa IDN. Albumin infusion in liver cirrhotic patients. Acta Med Indones. 2010;42(3):162-168. doi:10.1267/science.040579197.
DOI: https://doi.org/10.22146/jmpf.30285
Article Metrics
Abstract views : 6862 | views : 60621Refbacks
- There are currently no refbacks.
Copyright (c) 2017 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.